Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Reckitt Benckiser Group plc
  6. News
  7. Summary
    RB.   GB00B24CGK77

RECKITT BENCKISER GROUP PLC

(RB.)
  Report
Delayed Quote. Delayed London Stock Exchange - 09/24 11:35:05 am
5853 GBX   +0.39%
09/24RECKITT : UBS reaffirms its Buy rating
MD
09/24RECKITT : Goldman Sachs reiterates its Neutral rating
MD
09/23RECKITT : Receives a Buy rating from JP Morgan
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Reckitt Benckiser Swung to 1st Half Loss on Higher Costs

07/27/2021 | 02:38am EDT

By Matteo Castia

Reckitt Benckiser Group PLC reported Tuesday a swing to pretax loss for the first half of the year on lower revenue and higher costs.

The consumer-goods company--which houses Dettol, Harpic and Durex among its brands--posted a pretax loss of 1.94 billion pounds ($2.68 billion) for the six months, including a hit of GBP3.20 billion from losses on assets held for sale and disposal of goodwill and brands. This compares with a profit of GBP1.44 billion in the year-earlier period.

Revenue came in at GBP6.60 billion, down from GBP6.91 billion the prior year. A consensus estimate taken from FactSet and based on three analysts' projections had forecast Reckitt Benckiser's first-half revenue at GBP6.72 billion.

The board declared an interim dividend of 73 pence, flat on the year.

"Cost inflation accelerated in the second quarter and it will take time to offset this headwind with productivity and pricing actions being implemented in the back half of the year and early next year," the FTSE 100 company said.

The increasing costs will largely offset the margin accretion from the $2.20-billion disposal of the IFCN China, which remains scheduled for completion in the second half, Reckitt Benckiser said.

Reckitt Benckiser also said it expects a weak third quarter due to the tough year-earlier comparatives but that its flu and cold business will pick up in the fourth quarter.

"Overall demand in the disinfectant category remains significantly higher than pre-Covid levels and the two-year stacked growth of our hygiene portfolio is up 34.1%," the company said.

Write to Matteo Castia at matteo.castia@dowjones.com

(END) Dow Jones Newswires

07-27-21 0237ET

All news about RECKITT BENCKISER GROUP PLC
09/24RECKITT : UBS reaffirms its Buy rating
MD
09/24RECKITT : Goldman Sachs reiterates its Neutral rating
MD
09/23RECKITT : Receives a Buy rating from JP Morgan
MD
09/23RECKITT : Jefferies reiterates its Neutral rating
MD
09/23EUROPEAN MIDDAY BRIEFING : European Stocks Rise After Fed; BOE Eyed
DJ
09/23FTSE 100 Seen Opening Higher, BOE Awaited
DJ
09/23RECKITT BENCKISER : Reaffirms FY21 Guidance as Trading Meets Expectations
MT
09/23RECKITT BENCKISER : Investor Seminar Series, and trading update
PU
09/23Reckitt Benckiser Performance Since July 27 in Line With Views
DJ
09/22RECKITT BENCKISER : Launching Our Investor Seminar Series
PU
More news
Analyst Recommendations on RECKITT BENCKISER GROUP PLC
More recommendations
Financials
Sales 2021 13 140 M 17 958 M 17 958 M
Net income 2021 765 M 1 046 M 1 046 M
Net Debt 2021 8 418 M 11 505 M 11 505 M
P/E ratio 2021 -43,1x
Yield 2021 2,98%
Capitalization 41 804 M 57 145 M 57 134 M
EV / Sales 2021 3,82x
EV / Sales 2022 3,78x
Nbr of Employees 43 500
Free-Float 96,7%
Chart RECKITT BENCKISER GROUP PLC
Duration : Period :
Reckitt Benckiser Group plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends RECKITT BENCKISER GROUP PLC
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Last Close Price 5 853,00 GBX
Average target price 7 062,05 GBX
Spread / Average Target 20,7%
EPS Revisions
Managers and Directors
Laxman Narasimhan Group Chief Executive Officer & Executive Director
Jeff Carr Chief Financial Officer & Executive Director
Christopher A. Sinclair Chairman
Aditya Sehgal Chief Operating Officer-Health
Nicandro Durante Senior Independent Director
Sector and Competitors
1st jan.Capi. (M$)
RECKITT BENCKISER GROUP PLC-10.53%57 145
PROCTER & GAMBLE COMPANY3.17%348 585
UNILEVER PLC-9.15%140 711
THE ESTÉE LAUDER COMPANIES INC.20.46%115 804
HINDUSTAN UNILEVER LIMITED14.55%87 277
COLGATE-PALMOLIVE COMPANY-10.38%64 638